Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of sodium bicarbonate on intrarenal RAS activity in chronic kidney disease with metabolic acidosis
2013-002037-38Phase 4Active
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium bicarbonate in metabolic acidosis and chronic kidney disease (CKD) (3 arms). Primary endpoints: Change in intrarenal renin–angiotensin system activity and Study completion at 4 weeks. Started Jul 2013; status: active.
02
Drugs
sodium bicarbonate
03
Conditions
metabolic acidosischronic kidney disease (CKD)
Beyond the preview
Go deeper on 2013-002037-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002037-38.